Activity: Participating in or organising an event › Participation in conference › Academic
Description
Efficacy And Safety Of Canakinumab In Patients With Systemic Juvenile Idiopathic Arthritis: Results From An Open-Label Long-Term Follow-Up Study - Pres Congres